Form 8-K - Current report:
SEC Accession No. 0001663577-24-000255
Filing Date
2024-09-30
Accepted
2024-09-27 19:50:41
Documents
13
Period of Report
2024-09-27
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K abti8k092724.htm   iXBRL 8-K 24880
  Complete submission text file 0001663577-24-000255.txt   191031

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abti-20240927.xsd EX-101.SCH 3036
3 XBRL LABEL FILE abti-20240927_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abti-20240927_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT abti8k092724_htm.xml XML 3232
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-156091 | Film No.: 241336293
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)